Pro-inflammatory cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), are elevated in the plasma of IPF patients [23] and have been shown to activate coagulation and impair fibrinolysis [24,25]. This evidence concerns the gene IL6 and idiopathic pulmonary fibrosis.